• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALT
Click for more information
0.00% 0.5¢

ANALYTICA LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Analytica Limited is engaged in the design, development and supply of Class I and II... Analytica Limited is engaged in the design, development and supply of Class I and II medical devices. The Company's segments include Medical devices and Corporate. The Medical devices segment's products include PeriCoach (Perineometer), ELF-2 and AutoStart burette. The Company's lead product is the PeriCoach System, an e-health treatment system for women suffering from stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone application. The device evaluates activity in pelvic floor muscles. The information is transmitted to a smartphone application and can be loaded to PeriCloud where physicians can monitor patient progress through Web portal. The Analytica Autostart Infusion System offers solution to regular monitoring and refilling of burettes in intravenous fluid infusion. The Autostart burette contains a float system that automatically restarts intra-venous (IV) fluid flow following infused delivery of the predetermined amount of a required medication.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
ALT Change in substantial holding22/10/10
ALT Notice of Annual General Meeting/Proxy Form14/10/10
ALT Annual Report to shareholders30/09/10
ALT Change of Registered Office Address06/09/10
ALT Preliminary Final ReportPRICE SENSITIVE30/08/10
ALT Appendix 4C - quarterlyPRICE SENSITIVE30/07/10
ALT Appendix 4C - quarterlyPRICE SENSITIVE27/04/10
ALT Section 708A(5)(e) Notice13/04/10
ALT Appendix 3B13/04/10
ALT +MLA and ALT sign licensing and distribution agreement13/04/10
ALT +Licensing and Distribution Agreement signed with MLAPRICE SENSITIVE12/04/10
ALT Change of Company Secretary01/04/10
ALT Appendix 3B12/03/10
ALT +AutoStart Burette recieves FDA ClearancePRICE SENSITIVE09/03/10
ALT Becoming a substantial holder02/03/10
ALT Appendix 3B02/03/10
ALT Appendix 4D and Half Yearly Report and AccountsPRICE SENSITIVE26/02/10
ALT Market UpdatePRICE SENSITIVE05/02/10
ALT Appendix 4C - quarterlyPRICE SENSITIVE29/01/10
ALT Appendix 3B22/01/10
ALT Market UpdatePRICE SENSITIVE24/12/09
ALT Correction- Details of Share Registry address23/12/09
ALT Details of Share Registry address21/12/09
ALT Change of Director's Interest Notice04/12/09
ALT Appendix 3B04/12/09
ALT Results of Meeting27/11/09
ALT Chairman's Address to Shareholders27/11/09
ALT Operations Managers AGM Presentation27/11/09
ALT +MLA and ALT sign Licensing and Distribution HOA26/11/09
ALT +Heads of AgreementPRICE SENSITIVE26/11/09
ALT Trading Halt Request25/11/09
ALT Trading HaltPRICE SENSITIVE25/11/09
ALT Response to an ASX Price QueryPRICE SENSITIVE05/11/09
ALT First Commercial Sale of Autostart BurettePRICE SENSITIVE02/11/09
ALT FDA 510(k) Application AcceptancePRICE SENSITIVE12/10/09
ALT Appendix 4C - quarterlyPRICE SENSITIVE01/10/09
ALT Notice of Annual General Meeting/Proxy Form25/09/09
ALT Full Year Statutory Accounts15/09/09
ALT Preliminary Final ReportPRICE SENSITIVE27/08/09
ALT Change of Director's Interest Notice27/08/09
ALT Change of Director's Interest Notice27/08/09
ALT Completion of Share Purchase Plan25/08/09
ALT Appendix 3B- Share Purchase Plan25/08/09
ALT Location of Share Registry24/08/09
ALT AutoStart Burette UpdatePRICE SENSITIVE13/08/09
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/07/09
ALT Final Director's Interest Notice22/07/09
ALT Letter to Ineligible Shareholders20/07/09
ALT Letter to Optionholders20/07/09
ALT Letter to Shareholders - SPP20/07/09
ALT SPP Rules20/07/09
ALT SPP AnnouncementPRICE SENSITIVE20/07/09
ALT Disclosure Notice- SPP20/07/09
ALT Company Update13/07/09
ALT Change of Director's Interest Notice18/06/09
ALT Change of Director's Interest Notice05/05/09
ALT Appendix 4C - quarterlyPRICE SENSITIVE29/04/09
ALT Investment in CBio LimitedPRICE SENSITIVE09/04/09
ALT Change of Director's Interest Notice03/04/09
ALT Half Yearly Report and AccountsPRICE SENSITIVE24/02/09
ALT AutoStart Burette UpdatePRICE SENSITIVE24/02/09
ALT Preliminary Half-Yearly ResultPRICE SENSITIVE18/02/09
ALT Change of Director's Interest Notice30/01/09
ALT Appendix 4C - quarterlyPRICE SENSITIVE29/01/09
ALT Appendix 3B16/01/09
ALT Change of Director's Interest Notice06/01/09
ALT Appendix 3B06/01/09
ALT Change of Director's Interest Notice24/12/08
ALT Change of Director's Interest Notice x 224/12/08
ALT Appendix 3B23/12/08
ALT Appendix 3B10/12/08
ALT AutoStart Burette Update10/12/08
ALT Letter to Optionholders05/12/08
ALT Option Exercise Form01/12/08
ALT Appendix 3B01/12/08
ALT Amendment to Change of Director's Interest Notice01/12/08
ALT Appendix 3B28/11/08
ALT Change of Director's Interest Notice x 428/11/08
ALT Results of Meeting26/11/08
ALT Operational Update to AGM26/11/08
ALT Chairman's Address to Shareholders26/11/08
ALT CORRECTION TO AUTOSTART BURETTE ANNOUNCEMENTPRICE SENSITIVE21/11/08
ALT Release of Autostart Burette in New ZealandPRICE SENSITIVE20/11/08
ALT Change in substantial holding
22/10/10
ALT Notice of Annual General Meeting/Proxy Form
14/10/10
ALT Annual Report to shareholders
30/09/10
ALT Change of Registered Office Address
06/09/10
ALT Preliminary Final Report
30/08/10PRICE SENSITIVE
ALT Appendix 4C - quarterly
30/07/10PRICE SENSITIVE
ALT Appendix 4C - quarterly
27/04/10PRICE SENSITIVE
ALT Section 708A(5)(e) Notice
13/04/10
ALT Appendix 3B
13/04/10
ALT +MLA and ALT sign licensing and distribution agreement
13/04/10
ALT +Licensing and Distribution Agreement signed with MLA
12/04/10PRICE SENSITIVE
ALT Change of Company Secretary
01/04/10
ALT Appendix 3B
12/03/10
ALT +AutoStart Burette recieves FDA Clearance
09/03/10PRICE SENSITIVE
ALT Becoming a substantial holder
02/03/10
ALT Appendix 3B
02/03/10
ALT Appendix 4D and Half Yearly Report and Accounts
26/02/10PRICE SENSITIVE
ALT Market Update
05/02/10PRICE SENSITIVE
ALT Appendix 4C - quarterly
29/01/10PRICE SENSITIVE
ALT Appendix 3B
22/01/10
ALT Market Update
24/12/09PRICE SENSITIVE
ALT Correction- Details of Share Registry address
23/12/09
ALT Details of Share Registry address
21/12/09
ALT Change of Director's Interest Notice
04/12/09
ALT Appendix 3B
04/12/09
ALT Results of Meeting
27/11/09
ALT Chairman's Address to Shareholders
27/11/09
ALT Operations Managers AGM Presentation
27/11/09
ALT +MLA and ALT sign Licensing and Distribution HOA
26/11/09
ALT +Heads of Agreement
26/11/09PRICE SENSITIVE
ALT Trading Halt Request
25/11/09
ALT Trading Halt
25/11/09PRICE SENSITIVE
ALT Response to an ASX Price Query
05/11/09PRICE SENSITIVE
ALT First Commercial Sale of Autostart Burette
02/11/09PRICE SENSITIVE
ALT FDA 510(k) Application Acceptance
12/10/09PRICE SENSITIVE
ALT Appendix 4C - quarterly
01/10/09PRICE SENSITIVE
ALT Notice of Annual General Meeting/Proxy Form
25/09/09
ALT Full Year Statutory Accounts
15/09/09
ALT Preliminary Final Report
27/08/09PRICE SENSITIVE
ALT Change of Director's Interest Notice
27/08/09
ALT Change of Director's Interest Notice
27/08/09
ALT Completion of Share Purchase Plan
25/08/09
ALT Appendix 3B- Share Purchase Plan
25/08/09
ALT Location of Share Registry
24/08/09
ALT AutoStart Burette Update
13/08/09PRICE SENSITIVE
ALT Appendix 4C - quarterly
31/07/09PRICE SENSITIVE
ALT Final Director's Interest Notice
22/07/09
ALT Letter to Ineligible Shareholders
20/07/09
ALT Letter to Optionholders
20/07/09
ALT Letter to Shareholders - SPP
20/07/09
ALT SPP Rules
20/07/09
ALT SPP Announcement
20/07/09PRICE SENSITIVE
ALT Disclosure Notice- SPP
20/07/09
ALT Company Update
13/07/09
ALT Change of Director's Interest Notice
18/06/09
ALT Change of Director's Interest Notice
05/05/09
ALT Appendix 4C - quarterly
29/04/09PRICE SENSITIVE
ALT Investment in CBio Limited
09/04/09PRICE SENSITIVE
ALT Change of Director's Interest Notice
03/04/09
ALT Half Yearly Report and Accounts
24/02/09PRICE SENSITIVE
ALT AutoStart Burette Update
24/02/09PRICE SENSITIVE
ALT Preliminary Half-Yearly Result
18/02/09PRICE SENSITIVE
ALT Change of Director's Interest Notice
30/01/09
ALT Appendix 4C - quarterly
29/01/09PRICE SENSITIVE
ALT Appendix 3B
16/01/09
ALT Change of Director's Interest Notice
06/01/09
ALT Appendix 3B
06/01/09
ALT Change of Director's Interest Notice
24/12/08
ALT Change of Director's Interest Notice x 2
24/12/08
ALT Appendix 3B
23/12/08
ALT Appendix 3B
10/12/08
ALT AutoStart Burette Update
10/12/08
ALT Letter to Optionholders
05/12/08
ALT Option Exercise Form
01/12/08
ALT Appendix 3B
01/12/08
ALT Amendment to Change of Director's Interest Notice
01/12/08
ALT Appendix 3B
28/11/08
ALT Change of Director's Interest Notice x 4
28/11/08
ALT Results of Meeting
26/11/08
ALT Operational Update to AGM
26/11/08
ALT Chairman's Address to Shareholders
26/11/08
ALT CORRECTION TO AUTOSTART BURETTE ANNOUNCEMENT
21/11/08PRICE SENSITIVE
ALT Release of Autostart Burette in New Zealand
20/11/08PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Chimeric clocks $4.17M R&D tax rebate from Canberra Chimeric Therapeutics (ASX:CHM) has confirmed its receipt of a $4.17M tax rebate from Canberra for R&D activities.
Chaos reigns markets – so let's take stock of where we're at ahead of December For many people, it feels like the world has been getting crazier each year since 2020 (or 2016.) It's likely to continue
Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke Southern Cross Gold Ltd has found 5.5 metres at 25.4 g/t, with drilling highlighting the presence of multiple zones of mineralisation
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.